Dr. Mocherla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5200 Harry Hines Blvd
Dallas, TX 75235Phone+1 214-590-4656Fax+1 713-559-3255
Education & Training
Indiana University School of MedicineFellowship, Infectious Disease, 1998 - 2000
University of ToledoResidency, Internal Medicine, 1995 - 1998
Gandhi Medical CollegeClass of 1988
Certifications & Licensure
TX State Medical License 1999 - 2026
WY State Medical License 2012 - 2014
MI State Medical License 1998 - 2002
IN State Medical License 1999 - 2001- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 3 citationsAtovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.Mamta K Jain, James A De Lemos, Darren K McGuire, Colby Ayers, Jennifer L Eitson
Frontiers in Pharmacology. 2022-01-01 - 97 citationsEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18 - 8 citationsDisseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis.Orlando Garner, Ana Ramirez-Berlioz, Alfredo Iardino, Satish Mocherla, Kalpana Bhairavarasu
The American Journal of Case Reports. 2017-12-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
